CO6280486A2 - Cis-imidazolinas quirales - Google Patents
Cis-imidazolinas quiralesInfo
- Publication number
- CO6280486A2 CO6280486A2 CO10036293A CO10036293A CO6280486A2 CO 6280486 A2 CO6280486 A2 CO 6280486A2 CO 10036293 A CO10036293 A CO 10036293A CO 10036293 A CO10036293 A CO 10036293A CO 6280486 A2 CO6280486 A2 CO 6280486A2
- Authority
- CO
- Colombia
- Prior art keywords
- och3
- group
- ch2ch3
- quirales
- imirazolinas
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97850607P | 2007-10-09 | 2007-10-09 | |
| US9275908P | 2008-08-29 | 2008-08-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6280486A2 true CO6280486A2 (es) | 2011-05-20 |
Family
ID=40149549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO10036293A CO6280486A2 (es) | 2007-10-09 | 2010-03-26 | Cis-imidazolinas quirales |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US8513239B2 (zh) |
| EP (2) | EP2325180A1 (zh) |
| JP (1) | JP5324586B2 (zh) |
| KR (1) | KR101203020B1 (zh) |
| CN (2) | CN104710408A (zh) |
| AR (1) | AR068742A1 (zh) |
| AU (1) | AU2008309759A1 (zh) |
| BR (1) | BRPI0817850A2 (zh) |
| CA (1) | CA2701932C (zh) |
| CL (1) | CL2008002982A1 (zh) |
| CO (1) | CO6280486A2 (zh) |
| CR (1) | CR11333A (zh) |
| ES (1) | ES2395210T3 (zh) |
| IL (1) | IL204653A0 (zh) |
| MA (1) | MA31754B1 (zh) |
| MX (1) | MX2010003868A (zh) |
| PE (1) | PE20090814A1 (zh) |
| RU (1) | RU2487127C2 (zh) |
| TW (1) | TW200916446A (zh) |
| WO (1) | WO2009047161A1 (zh) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5683489B2 (ja) * | 2009-01-12 | 2015-03-11 | アレイ バイオファーマ、インコーポレイテッド | ピペリジン含有化合物およびその用途 |
| WO2010132873A2 (en) * | 2009-05-15 | 2010-11-18 | Northwestern University | Chiral pyrrolidine core compounds en route to inhibitors of nitric oxide synthase |
| MY160471A (en) | 2009-12-17 | 2017-03-15 | Centrexion Therapeutics Corp | New ccr2 receptor antagonists and uses thereof |
| US20130143905A1 (en) | 2009-12-17 | 2013-06-06 | Boehringer Ingelheim International Gmbh | Novel antagonists for ccr2 and uses thereof |
| EP2569298B1 (en) | 2010-05-12 | 2015-11-25 | Boehringer Ingelheim International GmbH | Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments |
| EP2576542B1 (en) | 2010-05-25 | 2015-04-22 | Boehringer Ingelheim International GmbH | Cyclic amide derivatives of pyridazine-3-carboxylic acids and their use in the treatment of pulmonary, pain, immune related and cardiovascular diseases |
| EP2576538B1 (en) | 2010-06-01 | 2015-10-28 | Boehringer Ingelheim International GmbH | New CCR2 antagonists |
| JO2998B1 (ar) | 2010-06-04 | 2016-09-05 | Amgen Inc | مشتقات بيبيريدينون كمثبطات mdm2 لعلاج السرطان |
| US9266860B2 (en) | 2010-09-30 | 2016-02-23 | St. Jude Children's Research Hospital | Aryl-substituted imidazoles |
| MX2013006739A (es) * | 2010-12-16 | 2013-07-17 | Roche Glycart Ag | Terapia combinada de anticuerpo cd20 afucosilado con inhibidor de mdm2. |
| JP6093770B2 (ja) | 2011-09-27 | 2017-03-08 | アムジエン・インコーポレーテツド | 癌の治療のためのｍｄｍ２阻害剤としての複素環化合物 |
| WO2014082889A1 (en) * | 2012-11-28 | 2014-06-05 | F. Hoffmann-La Roche Ag | Novel imidazolines as dual inhibitors of mdm2 and mdmx |
| US8846657B2 (en) | 2012-12-20 | 2014-09-30 | Merck Sharp & Dohme Corp. | Substituted imidazopyridines as HDM2 inhibitors |
| US11407721B2 (en) | 2013-02-19 | 2022-08-09 | Amgen Inc. | CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer |
| EP2961735B1 (en) | 2013-02-28 | 2017-09-27 | Amgen Inc. | A benzoic acid derivative mdm2 inhibitor for the treatment of cancer |
| PT2968316T (pt) | 2013-03-13 | 2019-10-29 | Forma Therapeutics Inc | Derivados de 2-hidroxi-1-{4-[(4-fenilfenil)carbonil]piperazin-1-il}etano-1-ona e compostos relacionados como inibidores da sintase de ácidos gordos (fasn) para o tratamento do cancro |
| CA2906538C (en) | 2013-03-14 | 2021-02-02 | Ana Gonzalez Buenrostro | Heteroaryl acid morpholinone compounds as mdm2 inhibitors for the treatment of cancer |
| JOP20200296A1 (ar) | 2013-06-10 | 2017-06-16 | Amgen Inc | عمليات صنع وأشكال بلورية من mdm2 مثبط |
| US10758525B2 (en) | 2015-01-22 | 2020-09-01 | MyoKardia, Inc. | 4-methylsulfonyl-substituted piperidine urea compounds |
| PL3458101T3 (pl) | 2016-05-20 | 2021-05-31 | F. Hoffmann-La Roche Ag | Koniugaty PROTAC-przeciwciało i sposoby ich stosowania |
| CN105906610B (zh) * | 2016-05-24 | 2018-10-23 | 绍兴文理学院 | 一种3-（4-苯基-1h-咪唑-5-基）-1h-吲哚衍生物及其制备方法和应用 |
| EP3415802B1 (en) | 2017-06-14 | 2019-08-28 | Borealis AG | Expansion joint |
| CN113382633A (zh) | 2018-10-29 | 2021-09-10 | 福马治疗股份有限公司 | (4-(2-氟-4-(1-甲基-1H-苯并[d]咪唑-5-基)苯甲酰基)哌嗪-1-基)(1-羟基环丙基)甲酮的固体形式 |
| WO2023056069A1 (en) | 2021-09-30 | 2023-04-06 | Angiex, Inc. | Degrader-antibody conjugates and methods of using same |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02101065A (ja) | 1988-10-06 | 1990-04-12 | Tanabe Seiyaku Co Ltd | イミダゾリン誘導体及びその製法 |
| GB2351082A (en) | 1999-06-18 | 2000-12-20 | Lilly Forschung Gmbh | Synthesis of Cyclic Substituted Amidines |
| EP1458380B1 (en) | 2001-12-18 | 2008-03-19 | F.Hoffmann-La Roche Ag | Cis-2,4,5- triphenyl-imidazolines and their use in the treatment of tumors |
| JP4361798B2 (ja) * | 2001-12-18 | 2009-11-11 | エフ．ホフマン−ラ ロシュ アーゲー | Ｍｄｍ２インヒビターとしてのシス−イミダゾリン |
| JP4814228B2 (ja) | 2004-05-18 | 2011-11-16 | エフ．ホフマン−ラ ロシュ アーゲー | 新規ｃｉｓ−イミダゾリン |
| ATE541121T1 (de) | 2005-07-08 | 2012-01-15 | Vestas Wind Sys As | Windturbine, nabe für eine windturbine und verwendung davon |
| CN101316823B (zh) * | 2005-12-01 | 2013-05-22 | 霍夫曼-拉罗奇有限公司 | 用作抗癌剂的作为p53和MDM2蛋白之间相互作用的抑制剂的2,4,5-三苯基咪唑啉衍生物 |
| KR101015073B1 (ko) * | 2006-01-18 | 2011-02-16 | 에프. 호프만-라 로슈 아게 | Ｍｄｍ2 억제제로서의시스-4,5-비아릴-2-헤테로시클릭-이미다졸린 |
-
2008
- 2008-09-30 BR BRPI0817850 patent/BRPI0817850A2/pt not_active Application Discontinuation
- 2008-09-30 MX MX2010003868A patent/MX2010003868A/es active IP Right Grant
- 2008-09-30 JP JP2010528361A patent/JP5324586B2/ja not_active Expired - Fee Related
- 2008-09-30 AU AU2008309759A patent/AU2008309759A1/en not_active Abandoned
- 2008-09-30 RU RU2010118018/04A patent/RU2487127C2/ru active
- 2008-09-30 EP EP10175975A patent/EP2325180A1/en not_active Withdrawn
- 2008-09-30 WO PCT/EP2008/063053 patent/WO2009047161A1/en active Application Filing
- 2008-09-30 KR KR1020107007374A patent/KR101203020B1/ko active IP Right Grant
- 2008-09-30 ES ES08837881T patent/ES2395210T3/es active Active
- 2008-09-30 CN CN201510024021.1A patent/CN104710408A/zh active Pending
- 2008-09-30 CN CN200880110704A patent/CN101821251A/zh active Pending
- 2008-09-30 EP EP08837881A patent/EP2203437B1/en active Active
- 2008-09-30 CA CA2701932A patent/CA2701932C/en not_active Expired - Fee Related
- 2008-10-07 CL CL2008002982A patent/CL2008002982A1/es unknown
- 2008-10-07 PE PE2008001740A patent/PE20090814A1/es not_active Application Discontinuation
- 2008-10-07 AR ARP080104381A patent/AR068742A1/es not_active Application Discontinuation
- 2008-10-08 TW TW097138773A patent/TW200916446A/zh unknown
- 2008-10-09 US US12/248,095 patent/US8513239B2/en active Active
-
2010
- 2010-03-22 IL IL204653A patent/IL204653A0/en unknown
- 2010-03-24 CR CR11333A patent/CR11333A/es not_active Application Discontinuation
- 2010-03-26 CO CO10036293A patent/CO6280486A2/es not_active Application Discontinuation
- 2010-04-05 MA MA32739A patent/MA31754B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0817850A2 (pt) | 2015-04-07 |
| JP5324586B2 (ja) | 2013-10-23 |
| KR20100051742A (ko) | 2010-05-17 |
| US8513239B2 (en) | 2013-08-20 |
| US20090111789A1 (en) | 2009-04-30 |
| AR068742A1 (es) | 2009-12-02 |
| EP2203437A1 (en) | 2010-07-07 |
| PE20090814A1 (es) | 2009-06-27 |
| EP2203437B1 (en) | 2012-11-07 |
| ES2395210T3 (es) | 2013-02-11 |
| CA2701932A1 (en) | 2009-04-16 |
| CR11333A (es) | 2010-06-21 |
| CA2701932C (en) | 2015-10-20 |
| CL2008002982A1 (es) | 2009-10-16 |
| CN101821251A (zh) | 2010-09-01 |
| KR101203020B1 (ko) | 2012-11-20 |
| RU2487127C2 (ru) | 2013-07-10 |
| MX2010003868A (es) | 2010-04-27 |
| AU2008309759A1 (en) | 2009-04-16 |
| EP2325180A1 (en) | 2011-05-25 |
| RU2010118018A (ru) | 2011-11-20 |
| JP2010540675A (ja) | 2010-12-24 |
| WO2009047161A1 (en) | 2009-04-16 |
| TW200916446A (en) | 2009-04-16 |
| IL204653A0 (en) | 2010-11-30 |
| CN104710408A (zh) | 2015-06-17 |
| MA31754B1 (fr) | 2010-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6280486A2 (es) | Cis-imidazolinas quirales | |
| RS52562B (en) | (3-ARIL-PIPERAZINE-1-IL) DERIVATI 6,7-DIALCOKSIQUINZOLINE, 6,7-DIALCOKSIFTALAZINE I | |
| ES2689037T3 (es) | Compuestos y composiciones antihelmínticas y procedimiento de utilización de los mismos | |
| EA201591429A1 (ru) | 2,3-дизамещенные производные 1-ацил-4-амино-1,2,3,4-тетрагидрохинолинов и их применение в качестве ингибиторов бромодомена | |
| CO6241076A2 (es) | Compuestos de benzamida y aplicaciones de los mismos | |
| ES2519446T3 (es) | Proceso para la preparación de ácido 4-amino-butírico sustituido con biarilo o derivados del mismo y su uso en la producción de inhibidores de NEP | |
| RS52261B (en) | AMIDOPHENOX INDASOLS AS A USEFUL C-MET INHIBITOR | |
| RS54848B1 (sr) | Nova pesticidna jedinjenja na bazi pirazola | |
| RS54375B1 (en) | TIOACETATE UNITS, COMPOSITIONS AND USE PROCEDURES | |
| AR009811A1 (es) | Compuestos herbicidas, proceso para su produccion, proceso para la produccion de intermediarios, compuestos intermediarios para su exclusivo usoen dicho proceso, composicion que tiene actividad herbicida selectiva y proceso para el control selectivo de malas hierbas y gramineas en cultivos de planta | |
| EA200971100A1 (ru) | Производные фталазинона в качестве ингибиторов поли(адф-рибоза)полимеразы (parp-1) | |
| AR067058A1 (es) | Oxazolidinonas sustituidas y su uso para preparar medicamentos | |
| ES2531410T3 (es) | Compuestos heterocíclicos y su uso como inhibidores de la glucógeno sintasa quinasa 3 | |
| ES2506169T3 (es) | Derivados de 5-fluoro-2-oxopirimidina-1(2H)-carboxilato como fungicidas | |
| PE20091901A1 (es) | Activadores de glucoquinasa | |
| RS51389B (en) | BENZIMIDAZOLE COMPOUNDS | |
| AR060813A1 (es) | Moduladores de mglur5 iii | |
| UA104449C2 (uk) | Комбінація, що містить метотрексат та інгібітор дгодг | |
| RS53569B1 (en) | NEW COMPOUNDS AND COMPOSITIONS, AND PROCEDURES FOR USE | |
| CO5700763A2 (es) | Derivados de 1-bencil-5-piperazin-1-il-3,4-dihidro-1h-quinazolin-2-ona y el respexctivo 1h-benzo (1,2,6)tiadiazin-2,2-dioxido y derivados de 1,4-dihidro-benzo (d) (1,3) oxazin-2-ona como moduladores del receptor 5-hidroxitriptamina (5-ht) para el tra | |
| RS53133B (en) | PIRAZOL DERIVATIVES USED AS CCR4 RECEPTOR ANTAGONISTS | |
| PH12019500664A1 (en) | New isoxazolyl ether derivatives as gaba a alpha5 pam | |
| ATE554066T1 (de) | Entzündungshemmende substituierte cyclobutendionverbindungen | |
| ES2563320T3 (es) | Tintes azoicos dispersos | |
| AR064415A1 (es) | Derivados de pirrolo-piperidinas y purinas,composiciones farmaceuticas que los contienen y usos en trastornos y/o enfermedades mediadas por pka y pkb. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Application withdrawn |